BALLERUP, Denmark--(BUSINESS WIRE)--Aug 28, 2018--LEO Pharma expands its Board of Directors with Olivier Bohuon who will join as vice chairman. With extensive experience in global pharmaceuticals and medical technology, Bohuon will contribute significantly to realising LEO Pharma’s strategy of being a global leader in medical dermatology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180828005286/en/

Olivier Bohuon elected to LEO Pharma's Board of Directors (Photo: Business Wire)

On August 27 th an extraordinary general meeting elected Olivier Bohuon as a new member of LEO Pharma’s Board of Directors. He will serve as the Board of Directors’ new vice chairman.

“I am excited to welcome Olivier Bohuon to LEO Pharma’s Board of Directors,” said Jukka Pertola, Chairman of LEO Pharma’s Board of Directors. “Olivier brings extensive strategic and commercial expertise in the global pharma industry. This will benefit LEO Pharma greatly as we are expanding into new innovative treatments in our ambition of being a global leader in medical dermatology,” Pertola continued.

“LEO Pharma is a company with a very strong vision. Its focus area of medical dermatology is strongly growing, highly competitive and benefiting from scientific advances in biotechnology. I am delighted to be able to help LEO Pharma succeed with its ambitious strategy,” said Olivier Bohuon.

Olivier Bohuon brings extensive experience in the global pharmaceutical and med-tech industry. He is board member of Smiths Group plc, senior independent director at Shire plc, supervisory board member at Virbac SA, and member of the National Pharmacy Academy and the Academy of Technologies. From 2011 to May 2018 Bohuon served as CEO of medical equipment specialist Smith & Nephew plc. Before that, he held positions as CEO at Laboratories Pierre Fabre, EVP, pharmaceutical products at Abbott Laboratories and SVP, director of European Commercial Operations at GlaxoSmithKline.

- ENDS -

About LEO Pharma

LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 130 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 5,200 people worldwide.

For more information, visit www.leo-pharma.com

Subscribe to our YouTube channel: www.youtube.com/leopharmaglobal

Follow us on Twitter: www.twitter.com/leohealthyskin

Visit us at LinkedIn: www.linkedin.com/company/leo-pharma

View source version on businesswire.com:https://www.businesswire.com/news/home/20180828005286/en/

CONTACT: LEO Pharma

Henrik Kyndlev

henrik.kyndlev@leo-pharma.com

+45 3140 6180

KEYWORD: EUROPE DENMARK

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: LEO Pharma

Copyright Business Wire 2018.

PUB: 08/28/2018 04:00 AM/DISC: 08/28/2018 04:01 AM

http://www.businesswire.com/news/home/20180828005286/en